Intestinal Bioprinted and Engineered Tissues for Regenerative Medicine
Source Cruz-Acuña et al., 2018 · Georgia Institute of Technology; University of Michigan · 10.1038/s41596-018-0036-3
Abstract
This protocol describes the synthesis and use of fully defined PEG-4MAL synthetic hydrogels to generate, culture, and deliver human pluripotent stem cell-derived organoids. The modular hydrogels replace Matrigel, offering tunable biochemical and biophysical properties to support robust in vitro organoid development and in vivo transplantation with minimal immune response.
Protocol overview
18 steps across 5 phases
- a Equilibrate hydrogel components to room temperature
- b Weigh hydrogel precursors
- c Dissolve peptides in HEPES buffer
- d Filter peptide and buffer solutions
- e Dissolve PEG-4MAL macromer
- f Generate functionalized PEG-4MAL macromer and incubate
- a Prepare spheroid or organoid suspension
- a Mix functionalized PEG-4MAL with biological suspension
- b Dispense cross-linker into culture wells
- c Pipette functionalized PEG-4MAL and cell mixture into cross-linker
- d Incubate hydrogels for cross-linking
- e Overlay hydrogels with culture medium
- a Monitor organoid growth and passage when ready
- a Induce colonic mucosal wounds (Day -1)
- b Prepare organoids for injection (Day 0, concurrent with wounding day +1 h)
- c Assemble custom injection device and load solutions
- d Mix organoids with functionalized PEG-4MAL and load syringe
- e Perform colonoscopic injection into wound
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method in Cruz-Acuña et al., 2018. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol